Top Stock Ideas Sent Daily — Join and Gain Your Edge
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Top Stock Ideas Sent Daily — Join and Gain Your Edge
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Halozyme Therapeutics
HALO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$56.64
-0.6
-1.05%
At Close: -
$56.64
0
0.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Halozyme Therapeutics (HALO) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Halozyme Therapeutics (NASDAQ:HALO) Stock
Halozyme Therapeutics Stock (NASDAQ: HALO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, September 19, 2024
JP Morgan Downgrades Halozyme Therapeutics to...
Benzinga Newsdesk
Monday, September 16, 2024
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Friday, September 13, 2024
(HALO) - Analyzing Halozyme Therapeutics's Short Interest
Benzinga Insights
Roche Group's Genentech Announces FDA Approve...
Benzinga Newsdesk
Critical Insights From Halozyme Therapeutics Analyst Ratings: What You Need To Know
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Reported Earlier, Roche's Genentech And Haloz...
Benzinga Newsdesk
Monday, August 26, 2024
Top 2 Health Care Stocks That May Plunge In August
Avi Kapoor
Tuesday, August 20, 2024
How Is The Market Feeling About Halozyme Therapeutics?
Benzinga Insights
Thursday, August 08, 2024
Benchmark Reiterates Buy on Halozyme Therapeu...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Wednesday, August 07, 2024
TD Cowen Maintains Buy on Halozyme Therapeuti...
Benzinga Newsdesk
Morgan Stanley Maintains Overweight on Halozy...
Benzinga Newsdesk
Halozyme Therapeutics shares are trading high...
Benzinga Newsdesk
Tuesday, August 06, 2024
Halozyme Therapeutics shares are trading high...
Benzinga Newsdesk
Halozyme Therapeutics Sees FY24 EPS $3.65-$4....
Benzinga Newsdesk
Halozyme Therapeutics Q2 Adj $0.91 Beats $0.7...
Benzinga Newsdesk
Theravance Q2 Loss Wider Than Expected, Revenues Rise Y/Y
Zacks
JP Morgan Maintains Overweight on Halozyme Th...
Benzinga Newsdesk
Thursday, August 01, 2024
(HALO) - Analyzing Halozyme Therapeutics's Short Interest
Benzinga Insights
Analyst Scoreboard: 14 Ratings For Halozyme Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Wednesday, July 31, 2024
United Therapeutics Q2 Earnings Lag, Sales Top Estimates
Zacks
Monday, July 22, 2024
Goldman Sachs Maintains Neutral on Halozyme T...
Benzinga Newsdesk
Tuesday, July 16, 2024
What 13 Analyst Ratings Have To Say About Halozyme Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Wednesday, June 26, 2024
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Tuesday, June 25, 2024
Benchmark Maintains Buy on Halozyme Therapeut...
Benzinga Newsdesk
Halozyme's OCREVUS SC Gets European Approval ...
Benzinga Newsdesk
Monday, June 24, 2024
Decoding 12 Analyst Evaluations For Halozyme Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Friday, June 14, 2024
Why Is Kodiak Sciences Down 26.2% Since Last Earnings Report?
Zacks
Sunday, June 09, 2024
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Lekha Gupta
Friday, June 07, 2024
This Exxon Mobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Avi Kapoor
Wells Fargo Maintains Overweight on Halozyme ...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Halozyme...
Benzinga Newsdesk
Piper Sandler Downgrades Halozyme Therapeutic...
Benzinga Newsdesk
Thursday, June 06, 2024
Halozyme's ENHANZE Product Gets New Patent Grant in EU
Zacks
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Halozyme Therapeutics +13% On Thursday: What's Going On?
Nabaparna Bhattacharya
J.M. Smucker Posts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Halozyme Therapeutics shares are trading high...
Benzinga Newsdesk
Halozyme Therapeutics Increases FY24 Adj. EPS...
Benzinga Newsdesk
Wednesday, June 05, 2024
Halozyme Receives Issuance Of New European Pa...
Benzinga Newsdesk
Tuesday, June 04, 2024
A Glimpse Into The Expert Outlook On Halozyme Therapeutics Through 8 Analysts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Wednesday, May 22, 2024
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Tuesday, May 21, 2024
Halozyme Discloses That Bristol Myers Squibb ...
Benzinga Newsdesk
Wednesday, May 08, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch